◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › MTD

Mettler-Toledo International Inc (MTD) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Life Sciences Tools & Services · DATA UPDATED 2026-07-16

Mettler-Toledo International Inc (MTD) operates in the Life Sciences Tools & Services industry and is headquartered in Greifensee, Switzerland with about 16,600 employees. Its market capitalization is roughly $27 billion. In the fiscal year ended 2025-12-31, MTD reported $4.0B in revenue and $869M in net income.

Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations.

Interactive charts & full statements → Open the MTD valuation workbench →

MTD Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$4.1B	$4.0B	$3.9B	$3.8B	$3.9B	$3.7B	$3.1B	$3.0B	$2.9B	$2.7B	$2.5B	$2.4B	$2.5B	$2.4B	$2.3B	$2.3B	$2.0B	$1.7B	$2.0B	$1.8B	$1.6B
Gross Profit	$2.4B	$2.3B	$2.3B	$2.2B	$2.2B	$2.1B	$1.7B	$1.7B	$1.6B	$1.5B	$1.4B	$1.3B	$1.3B	$1.3B	$1.2B	$1.2B	$1.0B	$877M	$983M	$884M	$779M
Gross Margin %	57.8%	57.5%	58.2%	59.2%	57.2%	56.7%	56.5%	56.2%	55.8%	56.3%	55.5%	55.7%	53.4%	52.9%	52.1%	52.0%	51.9%	50.8%	49.8%	49.3%	48.8%
Operating Income (EBIT)	$1.1B	$1.1B	$1.1B	$1.2B	$1.1B	$995M	$784M	$728M	$683M	$610M	$540M	$514M	$477M	$450M	$423M	$381M	$335M	$283M	$300M	$263M	$214M
Operating Margin %	28.0%	27.8%	29.1%	30.4%	28.7%	26.8%	25.4%	24.2%	23.3%	22.4%	21.5%	21.4%	19.2%	18.9%	18.1%	16.5%	17.1%	16.4%	15.2%	14.7%	13.4%
Net Income	$875M	$869M	$863M	$789M	$873M	$769M	$603M	$561M	$513M	$376M	$384M	$353M	$338M	$306M	$291M	$269M	$232M	$173M	$203M	$179M	$158M
Net Margin %	21.4%	21.6%	22.3%	20.8%	22.3%	20.7%	19.5%	18.6%	17.5%	13.8%	15.3%	14.7%	13.6%	12.9%	12.4%	11.7%	11.8%	10.0%	10.3%	10.0%	9.9%
EBITDA	$1.3B	$1.2B	$1.2B	$1.2B	$1.2B	$1.1B	$886M	$812M	$771M	$685M	$600M	$558M	$529M	$482M	$457M	$419M	$371M	$291M	$331M	$302M	$260M
Earnings Per Share (EPS)	$42.69	$42.17	$40.48	$35.90	$38.41	$32.78	$24.91	$22.47	$19.88	$14.24	$14.22	$12.48	$11.44	$9.96	$9.14	$8.21	$6.80	$5.03	$5.79	$4.70	$3.86
Shares Outstanding (M)	20M	21M	21M	22M	23M	23M	24M	25M	26M	26M	27M	28M	30M	31M	32M	33M	34M	34M	35M	38M	41M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MTD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$947M	$1.1B	$1.0B	$983M	$884M	$1.0B	$955M	$947M
Gross Profit	$556M	$656M	$589M	$562M	$509M	$621M	$554M	$547M
Gross Margin %	58.7%	58.1%	57.2%	57.2%	57.6%	59.4%	58.1%	57.8%
Operating Income (EBIT)	$246M	$343M	$290M	$266M	$220M	$334M	$278M	$266M
Operating Margin %	26.0%	30.4%	28.1%	27.0%	24.8%	31.9%	29.2%	28.1%
Net Income	$169M	$286M	$217M	$202M	$164M	$252M	$212M	$222M
Net Margin %	17.9%	25.3%	21.1%	20.6%	18.5%	24.1%	22.2%	23.4%
EBITDA	$259M	$377M	$320M	$296M	$248M	$363M	$312M	$296M
Earnings Per Share (EPS)	$8.35	$14.02	$10.57	$9.74	$7.84	$11.96	$9.94	$10.37
Shares Outstanding (M)	20M	20M	21M	21M	21M	21M	21M	21M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MTD Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$901M	$956M	$968M	$966M	$859M	$909M	$725M	$603M	$565M	$516M	$443M	$427M	$419M	$346M	$328M	$281M	$268M	$233M	$224M	$228M	$192M
Capital Expenditures (CapEx)	$107M	$107M	$104M	$105M	$121M	$108M	$92M	$97M	$143M	$127M	$124M	$83M	$89M	$82M	$96M	$98M	$74M	$60M	$61M	$48M	$34M
Free Cash Flow (FCF)	$794M	$849M	$864M	$861M	$738M	$801M	$632M	$506M	$422M	$389M	$319M	$344M	$330M	$264M	$232M	$182M	$194M	$173M	$163M	$181M	$157M
FCF Margin %	19.4%	21.1%	22.3%	22.7%	18.8%	21.6%	20.5%	16.8%	14.4%	14.3%	12.7%	14.4%	13.3%	11.1%	9.9%	7.9%	9.9%	10.0%	8.2%	10.1%	9.9%
Dividends Paid	—	—	—	$19M	—	$20M	$27M	$48M	—	$0M	$0M	$0M	$0M	$0M	$0M	$0M	$0M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MTD Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$140M	$226M	$299M	$236M	$194M	$266M	$255M	$258M
Capital Expenditures (CapEx)	$17M	$42M	$24M	$24M	$17M	$41M	$21M	$24M
Free Cash Flow (FCF)	$122M	$184M	$275M	$212M	$177M	$225M	$233M	$234M
FCF Margin %	12.9%	16.3%	26.7%	21.6%	20.1%	21.5%	24.4%	24.7%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

MTD Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$3.7B	$3.7B	$3.2B	$3.4B	$3.5B	$3.3B	$2.8B	$2.8B	$2.6B	$2.5B	$2.2B	$2.0B	$2.0B	$2.2B	$2.0B	$2.2B	$2.3B	$1.7B	$1.7B	$1.7B	$1.6B
Cash & Cash Equivalents	$61M	$67M	$59M	$70M	$96M	$99M	$94M	$208M	$178M	$149M	$159M	$99M	$85M	$112M	$102M	$236M	$448M	$85M	$78M	$81M	$151M
Total Liabilities	$3.7B	$3.7B	$3.4B	$3.5B	$3.5B	$3.2B	$2.5B	$2.4B	$2.0B	$2.0B	$1.7B	$1.4B	$1.3B	$1.2B	$1.2B	$1.4B	$1.5B	$1.0B	$1.2B	$1.1B	$956M
Total Debt (Short + Long-Term)	$2.2B	$2.2B	$2.0B	$2.1B	$2.0B	$1.7B	$1.3B	$1.3B	$1.0B	$980M	$894M	$590M	$452M	$413M	$389M	$505M	$681M	$294M	$454M	$397M	$356M
Total Shareholders' Equity	($42M)	($24M)	($127M)	($150M)	$25M	$171M	$283M	$421M	$590M	$547M	$435M	$580M	$720M	$935M	$827M	$781M	$772M	$711M	$503M	$581M	$631M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MTD viewer.

Other Companies in Life Sciences Tools & Services

DHR · Danaher Corporation — $135 billion
A · Agilent Technologies — $39 billion
WAT · Waters Corporation — $37 billion
IQV · IQVIA — $35 billion
TECH · Bio-Techne — $11 billion
CRL · Charles River Laboratories — $11 billion
TMO · Thermo Fisher Scientific — $211 billion

← MTCH All stocks MTDR →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.